Back
ProShares VIX Short-Term Futures ETF Vs. Ascendis Pharma A/S Industry Stock Comparison
Sell
1
VIXY
ProShares VIX Short-Term Futures ETF
Last Price:
$26.21
Seasonality Move:
0.94%
Sell
48
ASND
Ascendis Pharma A/S
Last Price:
$212.84
Seasonality Move:
17.83%
Sell
1
ProShares VIX Short-Term Futures ETF (VIXY)
is a Sell
Is ProShares VIX Short-Term Futures ETF a Buy, Sell or Hold?
-
The current ProShares VIX Short-Term Futures ETF [VIXY] share price is $26.19. The Score for VIXY is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
VIXY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
-
The current Ascendis Pharma A/S [ASND] share price is $212.81. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VIXY Stock Price Chart
What is ProShares VIX Short-Term Futures ETF's stock price today?
-
The ProShares VIX Short-Term Futures ETF share price today is $26.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIXY is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $212.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight selling pressure.
VIXY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.64 | Buy |
| Relative Strength Index (14 RSI): | 28.39 | Sell |
| Chaikin Money Flow: | 116591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.61 - 33.93) | Sell |
| Bollinger Bands (100): | (30.37 - 36.85) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 54.94 | Buy |
| Chaikin Money Flow: | -31407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.35 - 213.07) | Buy |
| Bollinger Bands (100): | (194.44 - 209.24) | Buy |
VIXY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Sell |
| 20-day SMA: | 29.42 | Sell |
| 50-day SMA: | 32.12 | Sell |
| 200-day SMA: | 43.37 | Sell |
| 8-day EMA: | 19.27 | Buy |
| 20-day EMA: | 10.69 | Buy |
| 50-day EMA: | 4.94 | Buy |
| 200-day EMA: | 1.33 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.43 | Buy |
| 20-day SMA: | 207.24 | Buy |
| 50-day SMA: | 205.88 | Buy |
| 200-day SMA: | 183.26 | Buy |
| 8-day EMA: | 208.12 | Buy |
| 20-day EMA: | 207.39 | Buy |
| 50-day EMA: | 205.31 | Buy |
| 200-day EMA: | 185.29 | Buy |
ProShares VIX Short-Term Futures ETF Earnings Growth & VIXY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.99 per share, and an increase next year of $7.73 per share.
ProShares VIX Short-Term Futures ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma A/S Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||